将该方法可应用于醋丁酰心安片、Acecor片、apo-醋丁洛尔片(醋丁洛尔标称含量400mg/片)和Acebirex片(醋丁洛尔标称含量200mg /片)中醋丁洛尔的含量测定，检出限(LOD)为0.04 mg/ml，定量限(LOQ)为0.12 mg/ml，RSD = 0.7~1.7% (n= 6)，片中无任何辅料干扰。标准加标法回收率为98.8%~102.4%。
Acebutolol hydrochloride has a reported solubility of 200 mg/mL in water, and 70 mg/mL in ethanol at room temperature. The hydrochloride salt is freely soluble in water. Acebutolol has been analyzed utilizing a colorimetric assay. The reported sensitivity of the assay is insufficient for ...
A 50-year-old man developed massive pleural thickening during treatment with acebutolol for systemic hypertension. The man, who had been receiving acebutolol 200mg daily [ route not stated ] for 9 years, was referred after a chest X-ray revealed bilateral large pleural opacities and a ...
最小起订100 mg支 供货总量999支 发货地址上海市奉贤区 建议售价￥376/支 更新日期 2025年04月25日 产品规格100 mg 即时洽谈 立即询价 查看联系方式 收藏产品 发送留言 举报 VIP4年 凯梅根(上海)生物科技有限公司 企业认证: 备 营业执照和法人身份证已备案 注册资本:200万 人民币 企业性质:私营...
药品名称:ACEBUTOLOL HYDROCHLORIDE,活性成分:ACEBUTOLOL HYDROCHLORIDE,剂型:CAPSULE;ORAL,规格:EQ 200MG BASE,药品注册申请号:074288,产品号:001
50 mg 405.00 53976ES70 200 mg 845.00 批量采购,请点击询价 下载产品说明书 产品说明书 FAQ COA 已发表文献 Acebutolol hydrochloride (Acebutolol HCl),又称盐酸醋丁洛尔或盐酸醋丁酰心安,是具有口服活性的β-肾上腺素能受体拮抗剂,具有内在拟交感活性和膜稳定作用,临床上常用于治疗用于治疗高血压、心绞痛和...
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态 001ACEBUTOLOL HYDROCHLORIDEACEBUTOLOL HYDROCHLORIDECAPSULE;ORALEQ 200MG BASENoNoNone1995/04/241995/04/24Discontinued ...
包装规格:10 mM * 1 mL;25 mg;50 mg;100 mg 品牌:MedChemExpress (MCE) 货号:HY-17497A 产地:美国 纯度:99.63% 是否进口:是 MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 Acebutolol MCE 国际站:Acebutolol hydrochloride 品牌:MedChemExpress (MCE) 货号:HY-1749...
In the present study, we assessed the antihypertensive efficacy of acebutolol 200 mg versus carvedilol 25 mg once daily, given as monotherapy for 3 months to 40 black patients (20 patients in each group, mean age 53 ± 10 years, 24 women) with mean blood pressure (BP) during the day ...
and then 1,200 mg. of acebutolol. Acebutolol (in a daily dose of 600 mg.) was an effective antianginal drug: the number of clinical attacks of angina pectoris (p < 0.001) and the consumption of sublingual nitrate decreased (p < 0.01), there was a significant increase in the ...